| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $95.5M | +17.9% |
| Cost of Revenue | $138.5M | -5.3% |
| R&D Expense | $18.9M | +20.4% |
| SG&A Expense | $36.6M | -1.3% |
| Operating Income | -$130.9M | +3.5% |
| Pre-tax Income | -$340.4M | -184.3% |
| Income Tax | -$2.0M | +39.0% |
| Net Income | -$338.4M | -190.6% |
| EPS (Basic) | -$1.66 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.0M | -47.8% |
| Short-term Investments | $1.1M | +0.0% |
| Accounts Receivable | $9.8M | +79.7% |
| Current Assets | $136.1M | -42.8% |
| Total Assets | $195.3M | -34.0% |
| Current Liabilities | $216.7M | +545.9% |
| Total Liabilities | $258.4M | +486.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.0M | +6.4% |
| Capital Expenditures | $2.7M | -81.7% |
| Investing Cash Flow | -$15.6M | +34.2% |
| Financing Cash Flow | -$1.7M | +22.5% |
| Free Cash Flow | -$89.7M | +16.6% |
| -186.2% |
| EPS (Diluted) | -$1.66 | -186.2% |
| Stockholders' Equity |
| -$63.1M |
| -125.1% |